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Stroke in Malawi – What do we know about it and 
How should we manage it?
AB is a 63-year-old tobacco farmer. He lives with his wife together 
with one of  his daughter’s family and 4 orphans from his deceased son. 
He occasionally smokes tobacco leaves. He does not have any regular 
medication. He was once given propranolol for 2 months owing to his 
high blood pressure, but it made him very tired. He did not go to get 
more medication after that.
One August morning, he could not get up from his bed, his speech was 
incomprehensible and he could not move the right side of  his body. He 
was brought to Queen Elizabeth Central Hospital.
CD is a 35-year-old mother of  4 living children, 2 other children having 
passed away. She is a business lady selling vegetables on Chileka road. 
A month before admission she had had shingles on her chest, however 
she was an otherwise healthy woman who did not consume alcohol or 
tobacco products.
One afternoon, on the way home she suddenly collapsed. Her daughter 
accompanied her to Queen Elizabeth Central Hospital.
1. What is a stroke?
WHO definition: 
● Rapidly developing clinical signs of  focal (at times global) 
disturbance of  cerebral function
● Clinical features last more than 24 hrs or lead to death.
● Presumed vascular origin
2. Is stroke different between blacks and whites
● In the age range 35 – 74 years blacks are nearly twice as 
likely to suffer a stroke as whites1,2
● Strokes in blacks tend to be more severe than in risk-
factor-matched whites3
● Black patients who survive have greater residual physical 
and functional deficits4
● The proportion of  strokes that are due to of  intracranial 
hemorrhage is higher in Africa than anywhere else: 27-31% 
of  all strokes5-7
3. Is stroke common here in Malawi?
● 80% of  strokes occur in developing countries, where 
incidence is increasing
● In Malawi, stroke is the 6th biggest killer (after infectious 
diseases) and a significant cause of  disability
● The population over 55 years is expected to increase by 
almost 50% by year 20208
● In January – March, 2007, QECH adult medical wards 
we had 55 admissions due to stroke (58% female). Inpatient 
mortality was 23%. Of  stroke patients HIV status was 
missing or unknown in 85% of  patients. In our Sept-Oct 
2007 stroke audit9 results were very similar.
4. What are the risk factors for stroke in African 
populations?
● In a South African study blacks experiencing strokes more 
commonly had underlying ischaemic heart disease, atrial 
fibrillation, valvular heart disease and dilated cardiomyopathy 
than whites5.
● There are no data on the impact of  hyperlipidaemia, obesity 
or genetic factors on stroke in Central or Southern Africa.
● Hypertension is the most important risk factor because it 
is the most common one and it can be treated. Individuals 
with BP less than 120/80 mmHg have 50% lower lifetime 
risk of  stroke than those with hypertension10.
● Hypertension is more common in blacks than whites. 
Hypothetized mechanisms include low serum renin levels, 
altered sodium handling within electrolyte channels and cells 
and genetic factors.11 Hypertension is not as angiotensin 
IIdependent in blacks as it is in whites.12
● 15% of  patients with stroke have diabetes in Sub-Saharan 
Africa, and 5% of  diabetic patients present with stroke at 
diagnosis.13
● Smoking and excessive alcohol drinking are separate global 
risk factors for stroke. 
HIV and other infections and stroke
● AIDS is strongly associated with both ischemic stroke and 
intracerebral hemorrhage in young adults (<44 years)14.
● Large-vessel cryptogenic stroke is more common in young 
(<50 year-old) HIV reactive patients than in HIV-nonreactive 
young stroke-patients.15
● In HIV reactive patients 80-90% of  the strokes are 
ischemic: 10-20 % is caused by HIV related vasculopathy. 
The other causes are vasculitis (10-50%), coagulopathy (10-
50%) and heart disease (10-40%).16
● ARVs can cause premature atherogenesis and thus ischemic 
stroke.16
● Neurosyphilis causes stroke, which in 35% of  cases occurs 
6-7 years after the original infection.17Syphilis is more 
common among HIV-reactive people than others.
● VDRL or RPR is positive in serum. Positive VDRL in 
CSF sample confirms the diagnosis of  neurosyphilis, but 
negative result does not rule it out. RPR cannot be used for 
CSF samples.17
● Any acute infection increases the risk of  having a stroke 
2-3 times. Patients with acute infection tend to have a worse 
outcome of  the stroke.18
AB was found out to be hypertensive. His smoking was an additional 
risk factor. He never took any alcohol. His cholesterol level was never 
measured. His mid upper arm circumference (MUAC) was 28 
cm, which is normal. He did not have HIV and VDRL was also 
negative.
CD was normotensive and blood sugar readings were normal. She 
had never smoked or drank alcohol. Her MUAC was 23 cm, which 
is normal.CD tested reactive for HIV, the shingles being the first 
manifestation of  her illness. Clinically she is WHO stage two, due 
to the shingles infection she had month ago. Stroke is not included in 
WHO staging of  HIV infection. Her CD4 count was tested and 
became 263 cells/µl. Her VDRL was nonreactive.
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5. How do we differentiate acute stroke from other 
causes of  focal neurological signs
● The most significant feature of  acute stroke is the abrupt 
onset without any preceding symptoms. There may be some 
progression or fluctuation of  symptoms during the first 
hours.
●Transient ischemic attack (TIA) is defined by stroke-like 
symptoms which recover completely within 24 hours and 
often within one hour.
● Important differentials diagnoses include central nervous 
system infection or tumour however these tend to develop 
more gradually.17
● Lumbar puncture analysis can help to detect intracerebral 
infection in patients with stroke-like symptoms – especially 
important in HIV reactive patients.6
6. What are the common stroke symptoms?
● Middle cerebral artery (most common site for stroke):
Contralateral hemiparesis and facial weakness with arm 
weaker than leg.
Dysphasia may occur with left hemispheric strokes whereas 
inattention predominates in right hemispheric strokes.
● Anterior cerebral artery
Contalateral hemiparesis with leg weaker than arm
● Posterior cerebral artery
Contralateral visual field loss (homonymous hemianopia)
● Cerebellar artery
Ipsilateral cerebellar signs (e.g. ataxia, dysdiadochokinesia, 
dysarthria)
● Basillar artery
Unconcsiousness, tetraparesis, cranial nerve lesions
7. Can we distinguish acute ischemic stroke from 
acute intracerebral
hemorrhage (ICH)?
● CT scans are the gold standard in the identification of  
stroke type.
● Ischemic strokes are known to occur more commonly 
in early morning hours while ICH is more likely to start 
when patient is active. Headache, vomiting and loss of  
consciousness are significantly more likely to occur in ICH 
than in ischemic stroke.
● But clinical features are not enough to distinguish 
haemorrhage from ischaemia.
● The Siriraj Stroke Score (SSS) was used in two Nigerian 
prospective multicentre trials altogether comprising 140 
patients with acute stroke.19,20 Here, the SSS had an overall 
predictive accuracy of  approximately 80%, sufficient for the 
authors to recommend its use in resource poor settings for 
epidemiological purposes and to guide management.
Surairaj stroke score=
(2.5 x consciousness) + (2 x vomiting) + (2 x head-
ache) +(0.1 x diastolic blood pressure mmHg) - (3 x 
atheroma) – 12
Consciousness: Alert = 0 Drowsy, stupor =1 Semi-
coma, coma =2
Vomiting: No =0 Yes =1
Headache within two hours of  onset: No = O Yes = 1
Atheroma markers (angina, diabetes, intermittent 
claudication)
None = O One or more =1
Interpretation: > +1 Haemorrhage <-1 = Infarction -1 
to +1 = Indeterminate
Unfortunately, when AB and CD were admitted to QECH 
the CT scan was broken.
AB was drowsy on admission. The right arm was not moving at all. 
He was moving slightly proximal part of  his right leg. He could not 
understand speech and only said: ”ee, ee”. He had right side facial 
weakness. The left side he was moving spontaneously. He was not 
vomiting, he did not have stigmata of  hyperlipidaemia. His blood 
pressure on admission was 160/100 mmHg. His SSS = (2.5 x 
1)+0+0+ (0.1 x 100 mmHg) - 0 – 12 = + 0.5. 
His stroke was indeterminate, but it was treated as an ischemic 
stroke.
CD was alert on admission and she did not report any vomiting. 
She had left side weakness of  her mouth and her speech was slurred. 
Strength in her left arm and leg was 3/5. She could not stand, but there 
was movement also on the distal part of  her upper and lower extremity. 
She had visual inattention to the left. Her BP was 110/70 mmHg on 
admission.
Her SSS = 0+0+0 (0.1 x 70 mmHg) – 0 – 12 = - 5. Her stroke 
was considered ischemic and it was treated as one.
8. How could we prevent people having strokes?
● The best stroke is the prevented one.
● Teach public about healthy lifestyle. Tobacco production is 
important for Malawian economy but stopping smoking can 
prevent a stroke. Malawian basic diet is quite healthy with its 
vegetables and beans and minimal use of  milk fats. Keeping 
the weight normal can also prevent a stroke.
● Evidence for non-pharmacological methods of  blood 
pressure reduction comes from two small randomised 
controlled trials in blacks: A low sodium diet21 and exercise22 
were associated with reductions in blood pressure, the latter 
demonstrating regression of  left ventricular hypertrophy.
● Prevention of  non-communicable diseases like stroke, 
cardiovascular diseases, diabetes and chronic respiratory 
diseases have many shared elements. As the population is 
aging in Malawi primary prevention programmes against 
these diseases are becoming more and more important.23
● Evidence for antihypertensive efficacy in blacks have 
overwhelmingly favoured calcium channel blockers and 
thiazide diuretics. The table below summarizes the data:
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Antihypertensive therapy according to the Malawi treatment 
guidelines (goal BP less than 140/90 mmHg:31
● moderate (160/100-180/110 mmHg) and severe 
(>180/>110 mmHg) hypertension should always be treated 
pharmacologically.
● Mild hypertension is only treated if  general measures are 
ineffective.
STEP 1:
● First drug of  choice is Hydrochlorthiazide 25 mg once 
daily or Bendrofluthiazide 2.5 mg daily.
STEP 2:
● Add in Amlodipine 5-10 mg daily or if  not available, 
Nifedipine 10-20 mg slow release tablets twice daily if  blood 
pressure is not controlled
STEP 3:
● If  this combination is not effective enough, Enalapril 10-20 
mg daily can be added to Amlodipine and Hydrochlorthiatside. 
Captopril 12.5-50 mg every 8 hours can be used if  Enalapril 
is not available.
STEP 4:
● If  the triple therapy does not work, Atenolol 50-100 mg 
daily can be added.
Propranolol is used if  Atenolol is not available.
● Medical specialist input is required where troublesome 
side effects are encountered, the patient is pregnant or if  this 
treatment strategy proves ineffective
9. How do we manage someone with acute 
stroke?
Investigations
● Fasting blood glucose (and random on admission), 
VDRL/RPR to look for syphilis, full blood count to look 
for anaemia, infections and platelet disorders.
● CT-scan of  the brain, without contrast, if  available.
Hypertension
● Thought to be due to cerebral autonomic regulation and 
generally improves over the following few days without 
recourse to therapy.
● Patient’s own antihypertensive therapy is continued if  
there is no hypotension <100/60 mmHg) If  hypertension is 
a new diagnosis for the patient 5-7 days can be waited before 
starting antihypertensives.
● Severe hypertension should be lowered: >220/120 mmHg 
in ischemic stroke, >180/100 mmHg in ICH or if  not known 
whether stroke is ischemic or bleed.
Oxygen therapy
● Evaluated in quasi-randomised trial: it showed no statistical 
differences in mortality or disability scores at one year and 
seven months respectively in acute stroke.33
● But: It seems reasonable to give supplemental oxygen to 
maintain saturations above 95% in acute stroke.
Hyperglycemia.
● Studies from Nigeria and the Democratic Republic of  
Congo demonstrated an association between hyperglycaemia 
in ischaemic stroke and increased mortality34,35 The association 
between admission hyperglycaemia and mortality in acute 
intracerebral haemorrhage has also been demonstrated.36
● While no studies have demonstrated prognostic benefit 
with blood glucose control, the treatment of  hyperglycaemia 
greater than 200mg/dl (11.1 mmol/l) with insulin is 
considered good practice.
Fever
● Treating fever improves the prognosis of  stroke.
● Acute infections should be treated. Most common of  
these are aspiration pneumonia and urinary tract infections 
in the elderly.
● Paracetamol can be given for fever of  unknown cause, if  
patient is able to swallow.32 Rectal paracetamol is an alternative. 
Intravenous paracetamol is not available in Malawi.
Rehydration
● Most patients are dehydrated when having acute stroke. 
Many patients are not able to swallow. Intravenous rehydration 
with non-glucose fluids is advisable.32
Swallow assessment
● Dysphagia is present in 50% of  acute strokes and is 
associated with poorer outcomes. The majority will return to 
their pre-stroke diet by six months.37
●The bedside swallow assessment (BSA) may be performed 
by personnel trained in its technique. This should only be for 
a fully alert, half  seated or seated, patient. A small volume 
of  water is given to the patient while a judgement is made 
about a change of  voice or respiratory pattern, coughing or 
pooling of  fluid within the oral cavity or leakage from the 
mouth.
● The BSA has a positive predictive value of  62% of  aspiration 
and a negative predictive value of  86% for aspiration.38
Aspirin
● In the Chinese acute stroke trial (CAST)39 (160mg/day for 
4 weeks) and the International Stroke Trial (300mg/day for 2 
weeks)40 aspirin demonstrated significant improvements in 
survival in acute ischemic stroke.
● In Malawi aspirin 75 mg/day is most commonly used.31 
For acute stroke, first dose of  300 mg of  aspirin can be given 













Less potent than CCB in some
studies25
Greater occurrence of diabetes28
ACEi/ARB Potent antihypertensive in
combination with thiazide or 
calcium channel blocker
Efficacy of ACEi as monotherpay
comparable to placebo28
Risk of angioedema28
Table 1: Antihypersensitive efficiency in blacks
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● In the absence of  a CT scan, the optimal treatment strategy 
is less certain. No study has yet assessed the risks and benefits 
of  aspirin therapy for suspected acute ischaemic stroke based 
on scoring systems. In the absence of  imaging, initiating low-
dose aspirin for acute ischaemic strokes as determined by the 
SSS19 seems reasonable.
Physiotherapy, occupational and speech therapy
● Start at day one if  possible for all acute stroke patients.31 
Malawi suffers with a shortage of  physiotherapists, 
occupational and speech therapists.
Rehabilitation technicians provide a valuable service 
in occupational and speech therapy in the absence of  
specialists.
● Kachere Rehabilitation Centre (KRC) trains rehabilitation 
technicians. The course is 3 years long.
● KRC provides the only institutional rehabilitation in 
Malawi.
● At QECH we have a weekly multidisciplinary meeting with 
clinicians, physiotherapists, rehabilitation technicians and 
representatives from KRC.
These meetings are used to review patient progress as identify 
future rehabilitation goals.
Preventing early complications (e.g. aspiration pneumonia, 
deep venous thrombosis) – the guardian’s role.
● Guardians need counselling and guidance in the care of  
stroke patients.
● Look after the patient’s hygiene, comfort, nutrition and 
sometimes medication.
● Ensure regular patient repositioning for pressure ulcer 
prevention.
● Avoid the feeding of  patients who are recumbent, have 
dysphagia or are drowsy or unconscious as this can be 
dangerous and lead to death through aspiration.
● Institute early physiotherapy with guidance from 
rehabilitation technicians.
10. How do we prevent another stroke?
● There is a 30-43% increased risk of  stroke within 5 years.
● Treating the cause of  the stroke with continuous assessment 
and medication helps preventing a new stroke.
● Optimise antihypertensive medication to a target of  < 
135/85 mmHg.
●Smoking cessation and treating diabetes is important
● All patients with ischemic or unknown cause of  stroke 
should continue Aspirintherapy for life!
● There are no data on the impact of  ARV-therapy on future 
stroke risk.
● Stroke is not a criterion in the WHO clinical staging for 
HIV. If  possible, obtain a CD4-vount in the HIV-reactive 
patient recovering from stroke, to guide ARV-therapy.
AB had swallowing difficulties and so administering oral drugs was 
very difficult. His antihypertensives were restarted with same problem. 
He was put on half  seated position to reduce his brain pressure. His 
temperature was normal. After 3 days from his stroke his temperature 
increased to 38.6ºC and his consciousness worsened (GCS 13/15). On 
auscultation there were anterior crepitations on basal area of  right lung. 
Ceftriaxone and metronidazole were started for aspiration pneumonia. 
The guardians were again advised not to give anything by mouth and 
nasogastric tube was inserted. 2 days later AB pulled the tube out and 
family refused him to have another tube. Fortunately as the infection 
resolved, repeat swallow assessment demonstrated improvement of  his 
dysphagia and he was able to swallow safely.
He was given daily physiotherapy at the ward. After 2 weeks he was 
discharged and went home. He was subsequently admitted to KRC 
where he stayed 6 weeks. There he was also given occupational therapy 
and assistance for communication. On discharge he was able to walk 
independently with support from onepoint stick. He was able to speak 
and understand few words, however still required help with washing 
and dressing. His blood pressure was controlled with a combination of  
propranolol and hydrochlordiazide, because Amlodipine or Enalapril 
were not available. He had stopped smoking.
CD had temperature of  38,2ºC on admission and paracetamolwas 
commenced. On clinical examination no cause for her fever was identified. 
She had 4 weeks old scar of  shingles on her chest on left side. CD was 
discharged by day four and by three weeks had made a virtual recovery 
with some mild clumsiness in her left hand and she kept forgetting to use 
it. Her CD4-count was 312 cells on discharge and so was not started 
on ARVs (below the threshold for starting ARVs at the time, which 
has now risen to 350 cells). She was asked to come again to ARV 
clinic 3 months later when she was put on ARVs. Unfortunately she 
stopped her Aspirin after one month from discharge and is at risk for 
further stroke.
11. What are the missed opportunities here in 
Malawi?
HIV- infection and high blood pressure are the leading causes 
of  stroke in Malawi.
The elderly population is increasing in Malawi. In our stroke 
audit most of  the patients did not know their HIV status 
after admission to QECH. Blood testing for diabetes and 
HIV status should be routinely collected from all stroke 
patients.
Educating the Malawian public, stroke patients and their 
guardians is crucial to reducing future risk of  stroke through 
more optimal monitoring of  blood pressure and ensure 
treatment is continued long term. The College of  Medicine 
is now training physiotherapists. This is very good news for 
all the stroke patients. The future may see more institutions 
like KRC offering institutional care and rehabilitation for 
stroke patients. Multi-disciplinary run stroke units have 
demonstrated effectiveness in reducing mortality in Sub 
Saharan Africa.41 The future may see the development of  
such units in Malawi.
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